Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.
Study Type
OBSERVATIONAL
Enrollment
300
ECMO for circulatory and/or respiratory support
The first affiliated hospital of nanjing medical university
Nanjing, Jiangsu, China
RECRUITINGComposite of death from any cause, resuscitated circulatory arrest, and implantation of another mechanical circulatory support device
Time frame: 30 days after ECMO implantation
All-cause mortality
Time frame: 30 days after ECMO implantation
All-cause mortality
Time frame: 12 months after ECMO implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.